Best Paper Hisada Prize Winners

As the 2022 Award for the Best Three Papers (Hisada Prize) selected from the Annals of Nuclear Medicine, the JSNM Board of Directors has selected:

Gold Prize

Comparison of ¹⁸F-FDG PET/CT and _⁶⁷Ga-SPECT for the diagnosis of fever of unknown origin: a multicenter prospective study in Japan

Annals of Nuclear Medicine 2021, 35(1), 31-46.

Kazuo Kubota, et al

Silver prize

Safety and efficacy of peptide receptor radionuclide therapy with ¹⁷⁷Lu-DOTA⁰-Tyr³-octreotate in combination with amino acid solution infusion in Japanese patients with somatostatin receptor-positive, progressive neuroendocrine tumors

Annals of Nuclear Medicine 2021, 35(12), 1332-1341.

Noritoshi Kobayashi, et al

Bronze Prize

Extended single-dose toxicity study of [2¹¹At]NaAt in mice for the first-in-human clinical trial of targeted alpha therapy for differentiated thyroid cancer

Annals of Nuclear Medicine 2021, 35(6), 702-718.

Tadashi Watabe, et al